DISSOCIATION OF NATURAL-KILLER AND LYMPHOCYTE-ACTIVATED KILLER-CELL LYTIC ACTIVITIES IN HUMAN CD3- LARGE GRANULAR LYMPHOCYTES

被引:11
作者
CLEMENT, MV [1 ]
LEGROSMAIDA, S [1 ]
SOULIE, A [1 ]
GUILLET, J [1 ]
SASPORTES, M [1 ]
机构
[1] HOP ST LOUIS,INSERM,U93,1 RUE CLAUDE VELLEFAUX,F-75010 PARIS,FRANCE
关键词
CD3- LARGE GRANULAR LYMPHOCYTES; NATURAL KILLER CELLS; LYMPHOCYTE-ACTIVATED KILLER CELLS; CELL LYSIS;
D O I
10.1002/eji.1830230319
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD3- large granular lymphocytes (LGL) are known to display natural killer cell (NK) activity without prior sensitization or restriction by major histocompatibility antigens. Upon short-term exposure to interleukin-2, NK cells were shown to acquire lymphocyte-activated killer cell (LAK) activity. The aim of this study was to analyze the characteristics of these lytic activities. Our data indicated that both NK and LAK activities were Ca2+ dependent; however, they could be dissociated by a Ca2+ channel blocker or a Ca2+ channel competitor agent. Moreover, NK activity was associated with granule exocytosis of lytic proteins spontaneously present in CD3- LGL, the most likely candidate being the pore-forming protein perforin. By contrast, LAK activity was found to be dependent on de novo protein synthesis and distinct from granule exocytosis. Our results strongly suggest that NK and LAK activities could be defined as two distinct pathways involving different lytic mediators.
引用
收藏
页码:697 / 701
页数:5
相关论文
共 28 条
[1]   GENERATION OF LYMPHOKINE-ACTIVATED KILLER CELLS - SYNERGY BETWEEN TUMOR NECROSIS FACTOR AND INTERLEUKIN-2 [J].
CHOUAIB, S ;
BERTOGLIO, J ;
BLAY, JY ;
MARCHIOLFOURNIGAULT, C ;
FRADELIZI, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (18) :6875-6879
[2]  
CLEMENT MV, 1991, RES IMMUNOL, V141, P477
[3]  
Dinarello C A, 1986, Year Immunol, V2, P68
[4]  
HEBERMAN RB, 1986, ANNU REV IMMUNOL, V4, P651
[5]  
ITOH K, 1985, J IMMUNOL, V134, P802
[6]  
LAFRENIERE R, 1985, CANCER RES, V45, P3735
[7]  
LANIER LL, 1991, J IMMUNOL, V146, P4421
[8]   STRUCTURE AND FUNCTION OF HUMAN PERFORIN [J].
LICHTENHELD, MG ;
OLSEN, KJ ;
LU, P ;
LOWREY, DM ;
HAMEED, A ;
HENGARTNER, H ;
PODACK, ER .
NATURE, 1988, 335 (6189) :448-451
[9]   IDENTIFICATION, ISOLATION, AND CHARACTERIZATION OF A NOVEL CYTOTOXIN IN MURINE CYTOLYTIC LYMPHOCYTES [J].
LIU, CC ;
STEFFEN, M ;
KING, F ;
YOUNG, JDE .
CELL, 1987, 51 (03) :393-403
[10]   INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELL THERAPY OF SOLID TUMORS - ANALYSIS OF TOXICITY AND MANAGEMENT GUIDELINES [J].
MARGOLIN, KA ;
RAYNER, AA ;
HAWKINS, MJ ;
ATKINS, MB ;
DUTCHER, JP ;
FISHER, RI ;
WEISS, GR ;
DOROSHOW, JH ;
JAFFE, HS ;
ROPER, M ;
PARKINSON, DR ;
WIERNIK, PH ;
CREEKMORE, SP ;
BOLDT, DH .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) :486-498